Home > News > Pharmaceutical News

RCC to market ViruSure services in India

Posted on Oct 23, 04:43PM | IANS

RCC Laboratories, a leading contract research organization, and Austrian firm ViruSure GmbH Tuesday announced their partnership to market the services of ViruSure in India.

Through this partnership, RCC will act as a sole agent for promoting ViruSure services in India, said the Hyderabad-based company which provides pre-clinical and safety toxicology and chemical testing globally.

Vienna-based ViruSure offers services in the areas of virus and prion safety testing for biopharmaceutical products, cell banking and cell bank characterization services and in vivo biosafety studies, according to a statement issued here.

"We look forward to offer our experience to assist Indian biopharmaceutical companies in reaching their goals for pathogen safety testing," said Andy Bailey, CEO and co-founder of ViruSure.

Both RCC and ViruSure will help Indian companies elevate their quality standards through their combined service offerings.

RCC offers its services to various companies in India and globally. With an experienced team of toxicologists, RCC is a leader in pre-clinical toxicology services in Asia.